期刊文献+

慢病毒携带shRNA对宫颈癌细胞中HPV16型E6表达的抑制作用 被引量:5

Inhibition of HPV16 E6 expression in cervical cancer cells by lentivirus mediated shRNA
下载PDF
导出
摘要 目的研究慢病毒携带的短发夹状干扰RNA(short hairp in RNA,shRNA)对宫颈癌Cask i细胞中人乳头瘤病毒(hum an pap illom a virus,HPV)16型E6表达的抑制作用。方法将靶向HPV16型E6的shRNA表达序列克隆到改建的慢病毒表达载体PLL3.7中,经限制性酶切鉴定和测序后,与3种包装质粒混合,以L ipofectam ine 2000包裹后转染293FT细胞,72 h后收取含病毒的上清液并感染宫颈癌Cask i细胞,感染48 h后加入G418筛选阳性克隆。每天对阳性细胞克隆进行细胞计数;提取细胞总mRNA,进行RT-PCR反应。结果与对照组相比HPV16型E6的表达降低70%,宫颈癌Cask i细胞生长速度减慢50%。结论慢病毒携带的短发夹状干扰RNA能干扰宫颈癌细胞中HPV16型E6的表达并有抑制癌细胞生长的作用。 Objective To investigate if lentivirus mediated short hairpin RNA (shRNA) could constantly inhibit HPV16 E6 expression in cervical cancer Caski cells. Methods Short hairpin RNA targeting to HPV16 E6 was cloned to lentivirus work vector ( lentilox RNAi vector PLL3.7 ). The recombined vector was identified by restriction enzyme analysis and sequencing. Work vector and three package plasmids were cotransfected to 293FT cells with the help of lipofectamine2000. Lentivirus was collected after 72 h, and was added to cultured Caski cells. Caski cells were screened by G418 at 48 h after infection. Cells were counted every day and total mRNA was extracted and underwent RT-PCR. Results Expression level of HPV16 E6 in Caski cells decreased by 70% as compared with controls. Cells growth velocity was reduced to 50% of controls. Conclusion Short hairpin RNA mediated by lentivirus can inhibit expression of HPV16 E6 and growth velocity of cervical cancer cells.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2006年第11期1218-1220,共3页 Journal of Third Military Medical University
基金 第三军医大学青年科研基金资助项目(2003)~~
关键词 宫颈癌 慢病毒 RNA干扰 人乳头瘤病毒 cervical cancer lentivirus RNA interfering human papilloma virus HPV
  • 相关文献

参考文献10

  • 1SCHEFFNER M,WHITAKER N J.Human papillomavirus-induced carcinogenesis and the ubiquitin-proteasome system[J].Semin Cancer Biol,2003,13(1):59-67. 被引量:1
  • 2郭建新,李力.HPV与宫颈癌疫苗研究进展[J].国外医学(妇幼保健分册),2004,15(6):395-398. 被引量:9
  • 3ELBASHIR S M,HARBORTH J,WEBER K,et al.Analysis of gene function in somatic mammalian cells using small interfering RNAs[J].Methods,2002,26(2):199-213. 被引量:1
  • 4BRANTL S.Antisense-RNA regulation and RNA interference[J].Biochim Biophys Acta,2002,1575(1-3):15-25. 被引量:1
  • 5ANDERSON S M.Human papillomavirus and cervical cancer[J].Clin Microbiol Newslett,2002,24(15):113-118. 被引量:1
  • 6YOSHINOUCHI M,YAMADA T,KIZAKI M,et al.In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by E6 siRNA[J].Mol Ther,2003,8(5):762-768. 被引量:1
  • 7BRUMMELKAMP T R,BERNARDS R,AGAMI R.A system for stable expression of short interfering RNAs in mammalian cells[J].Science,2002,296(5567):550-553. 被引量:1
  • 8LIU C M,LIU D P,DONG W J,et al.Retrovirus vector-mediated stable gene silencing in human cell[J].Biochem Biophys Res Commun,2004,313(3):716-720. 被引量:1
  • 9NISHITSUJI H,IKEDA T,MIYOSHI H,et al.Expression of small hairpin RNA by lentivirus-based vector confers efficient and stable gene-suppression of HIV-1 on human cells including primary non-dividing cells[J].Microbes Infect,2004,6(1):76-85. 被引量:1
  • 10OIKAWA K,OHBAYASHI T,KIYONO T,et al.Expression of a novel human gene,human wings apart-like (hWAPL),is associated with cervical carcinogenesis and tumor progression[J].Cancer Res,2004,64(10):3545-3549. 被引量:1

二级参考文献19

  • 1He Z, Wlazlo A P, Kowalczyk D W, et al. Viral recombinant vaccines to the E6 and E7 antigens of HPV-16[J]. Virology,2000,270:146 - 161. 被引量:1
  • 2Ressing M E, van Driel W J, Brandt R M, et al. Detection of T helper responses, but not of human papillomavirus-specific eytotoxic T lymphocyte responses, after peptide vaccination of patients with cervical carcinoma[J]. J Immunother, 2000,23:255 - 266. 被引量:1
  • 3Muderspach L, Wilczynski S, Roman L, et al. A phase I trial of a human papillomavirus (HPV) peptide vaccine for women with high-grade cervical and vulvar intraepithelial neoplasia who are HPV 16 positive[J]. Clin Cancer Res,2000,6:3406-3416. 被引量:1
  • 4Steller M A. Human papillomavirus, it's genes and cancer vaccines[J]. Cancer Cell,2003,3:7 - 8. 被引量:1
  • 5Wakabayashi M T, DaSilva D M, Potkul R K, et al. Comparison of human papillomavirus type 16 L1 chimeric virus-like particles versus L1/L2 chimeric virus-like particles in tumor prevention[J].Intervirology, 2002,45: 300 - 307. 被引量:1
  • 6Billich A. HPV vaccine medImmune/glaxo smith kline [ J ].Curr Opin Investig Drugs,2003,4:210- 213. 被引量:1
  • 7Steller M A. Cervical cancer vaccines: progress and prospects[J]. J Soc Gynecol Investig,2002,9:254- 264. 被引量:1
  • 8Bernard H U. Gene expression of genital human papillomaviruses and considerations on potential antiviral approaches [ J ]. Antivir Ther,2002,7:219 - 237. 被引量:1
  • 9Sanders G D, Taira A V. Cost-effectiveness of a potential vaccine for human papillomavirus [ J ]. Emerg Infect Dis,2003,9:37 - 48. 被引量:1
  • 10Plummer M, Franceschi S. Strategies for HPV prevention[J].Virus Res,2002,89:285 - 293. 被引量:1

共引文献8

同被引文献60

引证文献5

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部